Skip to content

Author

Luca Sgarra

We have 4 of 15 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Cardiometabolic Substrate Modification in Atrial Fibrillation: Obesity and Epicardial Adipose Tissue in the Era of Incretin-Based Therapies and Catheter Ablation

Atrial fibrillation (AF) is increasingly understood as the electrical expression of a systemic and atrial cardiometabolic disease rather than an isolated disorder of pulmonary-vein triggers. Obesity, insulin resistance, hypertension, sleep-disordered breathing, heart failure with preserved ejection fraction, and viscer...

A. Matteucci, M. Bonanni, Luca Sgarra et al. · 0 citations
Review Open access Sep 2026

Non-Dilated Left Ventricular Cardiomyopathy: Exploring the Spectrum from Phenotype to Disease Entity

Non-dilated left ventricular cardiomyopathy has recently emerged as a distinct morpho-functional phenotype defined by non-ischemic left ventricular scarring or fatty replacement or by isolated global left ventricular hypokinesia without scarring in the absence of ventricular dilatation. Whether it represents a distinct...

F. Mangini, Massimo Grimaldi, A. di Monaco et al. · 0 citations
Review Open access Sep 2026

Wearable Cardioverter-Defibrillator in Patients at Transient Risk of Sudden Cardiac Death: State of the Art and Contemporary Clinical Evidence

Overall, current evidence supports the technical efficacy of the WCD for terminating sustained ventricular tachyarrhythmias, but observational shock rates do not establish a population-level survival benefit.

A. Matteucci, M. Bonanni, M. Mariani et al. · 0 citations
Case report Open access Aug 2026

Novel Insights from Blood Speckle Imaging for the Assessment of Left Ventricular Flow Dynamics in Adult Patients: A Three‐Patient Proof‐of‐Concept Case Series in the Context of Current Evidence

Observations support the hypothesis that flow reorganization may represent an early marker of ventricular recovery preceding detectable structural remodeling and require prospective validation against quantitative four‐dimensional flow cardiovascular magnetic resonance.

F. Mangini, Massimo Grimaldi, N. Vitulano et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.